Henry Schein Inc., a leading healthcare solutions provider, has secured a $250 million investment from private equity powerhouse KKR, making KKR the company’s largest non-index fund shareholder, according to a Wednesday announcement.
KKR, advised by Kirkland & Ellis LLP, will acquire a 12% stake in Henry Schein, with the ability to expand its holdings through open market purchases to a total equity position of 14.9%. Cleary Gottlieb Steen & Hamilton LLP advised Henry Schein on the transaction.
Strategic Growth and Partnership with KKR
Henry Schein, which serves over 1 million dental and medical professionals globally, sees the investment as a strategic move to enhance its growth, capital allocation, and operational strategy.
“Our board and management have great respect for KKR, including its partnership-oriented approach and experience in supporting value creation across its investments,” said Stanley Bergman, Chairman and CEO of Henry Schein. “This is a testament to the hard work of Team Schein to advance our leadership as a solutions-driven innovator for health care professionals.”
